Company News

GlaxoSmithKline will extend its strategic collaboration with Aspen, a pharmaceutical manufacturer, through the acquisition of a 16% shareholding in the company. In return, Aspen received the right to distribute GSK products in South Africa. Aspen is the largest generics manufacturer in the southern hemisphere, according to the company's website.

 

Sanofi-Aventis announced that it will acquire commercial rights to Oforta, a leukemia treatment manufactured by Antisoma, for $60 million, with further payments totaling $5 million. Antisoma is a biotech based in London and Boston.

You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.